Harvard Bioscience Stock Forward View
| HBIO Stock | USD 0.50 0.04 7.41% |
Harvard Stock outlook is based on your current time horizon. Although Harvard Bioscience's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Harvard Bioscience's systematic risk associated with finding meaningful patterns of Harvard Bioscience fundamentals over time.
As of today, the relative strength index (RSI) of Harvard Bioscience's share price is approaching 38. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Harvard Bioscience, making its price go up or down. Momentum 38
Sell Extended
Oversold | Overbought |
Quarterly Earnings Growth (0.80) | EPS Estimate Next Quarter 0.04 | EPS Estimate Current Year 0.03 | EPS Estimate Next Year 0.095 | Wall Street Target Price 2 |
Using Harvard Bioscience hype-based prediction, you can estimate the value of Harvard Bioscience from the perspective of Harvard Bioscience response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Harvard Bioscience using Harvard Bioscience's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Harvard using crowd psychology based on the activity and movement of Harvard Bioscience's stock price.
Harvard Bioscience Implied Volatility | 3.03 |
Harvard Bioscience's implied volatility exposes the market's sentiment of Harvard Bioscience stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Harvard Bioscience's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Harvard Bioscience stock will not fluctuate a lot when Harvard Bioscience's options are near their expiration.
The Naive Prediction forecasted value of Harvard Bioscience on the next trading day is expected to be 0.49 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 1.50. Harvard Bioscience after-hype prediction price | USD 0.5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Harvard Bioscience to cross-verify your projections. Open Interest Against 2026-03-20 Harvard Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Harvard Bioscience's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Harvard Bioscience's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Harvard Bioscience stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Harvard Bioscience's open interest, investors have to compare it to Harvard Bioscience's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Harvard Bioscience is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Harvard. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Harvard Bioscience Additional Predictive Modules
Most predictive techniques to examine Harvard price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Harvard using various technical indicators. When you analyze Harvard charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Harvard Bioscience Cash Forecast
Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Harvard Bioscience's financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 2000-12-31 | Previous Quarter 7.4 M | Current Value 6.8 M | Quarterly Volatility 9 M |
Harvard Bioscience Naive Prediction Price Forecast For the 2nd of February
Given 90 days horizon, the Naive Prediction forecasted value of Harvard Bioscience on the next trading day is expected to be 0.49 with a mean absolute deviation of 0.02, mean absolute percentage error of 0.0009, and the sum of the absolute errors of 1.50.Please note that although there have been many attempts to predict Harvard Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Harvard Bioscience's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Harvard Bioscience Stock Forecast Pattern
| Backtest Harvard Bioscience | Harvard Bioscience Price Prediction | Buy or Sell Advice |
Harvard Bioscience Forecasted Value
In the context of forecasting Harvard Bioscience's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Harvard Bioscience's downside and upside margins for the forecasting period are 0.01 and 5.77, respectively. We have considered Harvard Bioscience's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Harvard Bioscience stock data series using in forecasting. Note that when a statistical model is used to represent Harvard Bioscience stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.1327 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0246 |
| MAPE | Mean absolute percentage error | 0.0379 |
| SAE | Sum of the absolute errors | 1.5036 |
Predictive Modules for Harvard Bioscience
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Harvard Bioscience. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Harvard Bioscience After-Hype Price Density Analysis
As far as predicting the price of Harvard Bioscience at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Harvard Bioscience or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Harvard Bioscience, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Harvard Bioscience Estimiated After-Hype Price Volatility
In the context of predicting Harvard Bioscience's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Harvard Bioscience's historical news coverage. Harvard Bioscience's after-hype downside and upside margins for the prediction period are 0.03 and 5.78, respectively. We have considered Harvard Bioscience's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Harvard Bioscience is abnormally volatile at this time. Analysis and calculation of next after-hype price of Harvard Bioscience is based on 3 months time horizon.
Harvard Bioscience Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Harvard Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Harvard Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Harvard Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.08 | 5.28 | 0.00 | 0.02 | 6 Events / Month | 5 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.50 | 0.50 | 0.00 |
|
Harvard Bioscience Hype Timeline
Harvard Bioscience is currently traded for 0.50. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.02. Harvard is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -0.08%. %. The volatility of related hype on Harvard Bioscience is about 2412.18%, with the expected price after the next announcement by competition of 0.48. About 46.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.7. Some equities with similar Price to Book (P/B) outperform the market in the long run. Harvard Bioscience has Price/Earnings To Growth (PEG) ratio of 2.89. The entity recorded a loss per share of 1.21. The firm had not issued any dividends in recent years. Harvard Bioscience had 1319:1000 split on the 4th of November 2013. Given the investment horizon of 90 days the next forecasted press release will be in about 6 days. Check out Historical Fundamental Analysis of Harvard Bioscience to cross-verify your projections.Harvard Bioscience Related Hype Analysis
Having access to credible news sources related to Harvard Bioscience's direct competition is more important than ever and may enhance your ability to predict Harvard Bioscience's future price movements. Getting to know how Harvard Bioscience's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Harvard Bioscience may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NXGL | Nexgel Inc | (0.02) | 8 per month | 0.00 | (0.12) | 12.42 | (8.18) | 35.89 | |
| RVP | Retractable Technologies | (0.01) | 7 per month | 0.00 | (0.22) | 2.63 | (3.57) | 10.11 | |
| FEMY | Femasys | (0.01) | 6 per month | 0.00 | (0.02) | 15.00 | (11.11) | 47.42 | |
| NXL | Nexalin Technology | 0.05 | 8 per month | 0.00 | (0.25) | 7.92 | (8.70) | 27.45 | |
| SONN | Sonnet Biotherapeutics Holdings | (0.58) | 8 per month | 0.00 | (0.02) | 19.48 | (18.21) | 69.59 | |
| TAOX | TAO Synergies | (1.22) | 9 per month | 0.00 | (0.09) | 12.66 | (10.43) | 36.28 | |
| NCNA | NuCana PLC | (0.28) | 6 per month | 0.00 | (0.18) | 6.97 | (7.87) | 16.72 | |
| COSM | Cosmos Health | (0.08) | 11 per month | 0.00 | (0.15) | 8.16 | (10.00) | 28.14 | |
| CLGN | Collplant Biotechnologies | 0.18 | 8 per month | 0.00 | (0.03) | 8.51 | (7.84) | 25.76 |
Other Forecasting Options for Harvard Bioscience
For every potential investor in Harvard, whether a beginner or expert, Harvard Bioscience's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Harvard Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Harvard. Basic forecasting techniques help filter out the noise by identifying Harvard Bioscience's price trends.Harvard Bioscience Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Harvard Bioscience stock to make a market-neutral strategy. Peer analysis of Harvard Bioscience could also be used in its relative valuation, which is a method of valuing Harvard Bioscience by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Harvard Bioscience Market Strength Events
Market strength indicators help investors to evaluate how Harvard Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Harvard Bioscience shares will generate the highest return on investment. By undertsting and applying Harvard Bioscience stock market strength indicators, traders can identify Harvard Bioscience entry and exit signals to maximize returns.
Harvard Bioscience Risk Indicators
The analysis of Harvard Bioscience's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Harvard Bioscience's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting harvard stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.01 | |||
| Semi Deviation | 4.98 | |||
| Standard Deviation | 7.68 | |||
| Variance | 58.94 | |||
| Downside Variance | 31.33 | |||
| Semi Variance | 24.78 | |||
| Expected Short fall | (6.51) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Harvard Bioscience
The number of cover stories for Harvard Bioscience depends on current market conditions and Harvard Bioscience's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Harvard Bioscience is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Harvard Bioscience's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Harvard Bioscience Short Properties
Harvard Bioscience's future price predictability will typically decrease when Harvard Bioscience's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Harvard Bioscience often depends not only on the future outlook of the potential Harvard Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Harvard Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 43.5 M | |
| Cash And Short Term Investments | 4.1 M |
Check out Historical Fundamental Analysis of Harvard Bioscience to cross-verify your projections. To learn how to invest in Harvard Stock, please use our How to Invest in Harvard Bioscience guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Will Life Sciences Tools & Services sector continue expanding? Could Harvard diversify its offerings? Factors like these will boost the valuation of Harvard Bioscience. Market participants price Harvard higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Harvard Bioscience data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.80) | Earnings Share (1.21) | Revenue Per Share | Quarterly Revenue Growth (0.06) | Return On Assets |
Harvard Bioscience's market price often diverges from its book value, the accounting figure shown on Harvard's balance sheet. Smart investors calculate Harvard Bioscience's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Harvard Bioscience's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Harvard Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harvard Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harvard Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.